June 2, 2020 / 10:08 PM / a month ago

BRIEF-L.I.A. Pure Capital Ltd Reports 12.58% Stake In Therapix Biosciences As Of May 31 2020

June 2 (Reuters) - Therapix Biosciences Ltd:

* L.I.A. PURE CAPITAL LTD REPORTS 12.58% STAKE IN THERAPIX BIOSCIENCES AS OF MAY 31 2020 - SEC FILING

* L.I.A. PURE CAPITAL LTD SAYS ACQUIRED THERAPIX BIOSCIENCES ADSS BECAUSE THEY BELIEVE THAT THE ADSS ARE UNDERVALUED

* L.I.A. PURE CAPITAL LTD SAYS INTENDS TO SEEK POSITIONS OF THERAPIX BIOSCIENCES’S BOARD AND MAY SEEK TO GAIN CONTROL INTEREST IN THERAPIX BIOSCIENCES Source text: (bit.ly/2XoZlwW) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below